Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Amplification of autoimmune disease by infection Posnett DN; Yarilin DArthritis Res Ther 2005[]; 7 (2): 74-84Reports of infection with certain chronic persistent microbes (herpesviruses or Chlamydiae) in human autoimmune diseases are consistent with the hypothesis that these microbes are reactivated in the setting of immunodeficiency and often target the site of autoimmune inflammation. New experimental animal models demonstrate the principle. A herpesvirus or Chlamydia species can be used to infect mice with induced transient autoimmune diseases. This results in increased disease severity and even relapse. The evidence suggests that the organisms are specifically imported to the inflammatory sites and cause further tissue destruction, especially when the host is immunosuppressed. We review the evidence for the amplification of autoimmune inflammatory disease by microbial infection, which may be a general mechanism applicable to many human diseases. We suggest that patients with autoimmune disorders receiving immunosuppressing drugs should benefit from preventive antiviral therapy.|Animals[MESH]|Antiviral Agents/administration & dosage/therapeutic use[MESH]|Autoimmune Diseases/*complications/immunology[MESH]|Biological Transport[MESH]|Chlamydia Infections/complications/immunology/prevention & control[MESH]|Chlamydophila Infections/complications/immunology/prevention & control[MESH]|Encephalomyelitis, Autoimmune, Experimental/complications/immunology[MESH]|Herpesviridae Infections/complications/immunology/prevention & control[MESH]|Humans[MESH]|Immunocompromised Host[MESH]|Immunosuppressive Agents/adverse effects/therapeutic use[MESH]|Inflammation[MESH]|Mice[MESH]|Models, Immunological[MESH]|Organ Specificity[MESH]|Parvoviridae Infections/complications/immunology/prevention & control[MESH]|Parvovirus B19, Human[MESH]|Rhadinovirus[MESH]|Tumor Virus Infections/complications/immunology[MESH]|Viremia/complications/immunology/prevention & control[MESH]|Virus Diseases/*complications/immunology/prevention & control[MESH]|Virus Replication[MESH] |